JPRN-UMIN000029360
Completed
未知
sefulness of topical heparinoid in the treatment of asteatosis in hemodialyzed patients - Usefulness of topical heparinoid in the treatment of asteatosis in hemodialyzed patients
ippon medical school hospital0 sites76 target enrollmentOctober 1, 2017
Conditionsasteatosis in hemodialyzed patient
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- asteatosis in hemodialyzed patient
- Sponsor
- ippon medical school hospital
- Enrollment
- 76
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Patients who received heparinoid\- or urea \-containing drugs, or petrolatum within three weeks before signing the consent form. (2\) Patients with/ with the past of extensive complications of the skin (burn, psoriasis etc.) (3\) Patients with allergy to heparinoid (4\) Patients with hemorrhagic blood disease (hemophilia, thrombocytopenia, purpura etc.) (5\) Patients who are expected a few bleeding causes a serious result. (6\) Patients who are pregnant, or possibly pregnant women. (7\)Patients who participated in other clinical study within 4 months before starting study. (8\) Patients who are unsuitable to the study at the investigator's discretion.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom.JPRN-UMIN000018986Osaka city university graduate school of medicine, department of dermatology50
Not yet recruiting
Phase 3
To test whether application of topical heparin solution around the IV cannula site daily would reduce the occurrence of superficial inflammation of veins when compared to a placeboHealth Condition 1: I809- Phlebitis and thrombophlebitis ofunspecified siteCTRI/2024/06/069653All India Institute of Medical Sciences, Mangalagiri
Completed
Phase 1
Prevention of local skin reaction by heparinoid due to rotigotine transdermal patch: a pilot randomized clinical trial.Parkinson's diseaseJPRN-UMIN000033409Wakayama Medical University20
Recruiting
Phase 3
The efficacy of topical Hydroquinon with and without using Erbium YAG LASER in treatment of melasmaMelasma.ChloasmaL81.1IRCT20181201041812N1Tehran University of Medical Sciences27
Completed
Not Applicable
Effect OF Heparin solution for prevention of pain and swelling at the site of peripheral intravenous catheter.Health Condition 1: O- Medical and SurgicalCTRI/2017/10/010089PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH100